Abstract
Background: During the remodeling process after myocardial infarction (MI), the expression of proinflammatory cytokines is enhanced in the myocardium. However, only a few clinical studies have been conducted on cytokine involvement in left ventricular (LV) remodeling after MI.
Hypothesis: Circulating proinflammatory cytokines may be involved in LV remodeling in patients with reperfused MI.
Methods: We studied 25 patients with acute anterior MI who had undergone coronary reperfusion therapy, and 10 normal control subjects with no cardiac disease. In all patients, LV ejection fraction, end‐diastolic volume index (EDVI), and end‐systolic volume index (ESVI) were determined using left ventriculography at the acute phase and 6 months after onset. The ΔEDVI and ΔESVI were calculated as the value of LV volume reduction, suggesting LV reverse remodeling. Serum levels of interleukin (IL)‐6 and tumor necrosis factor (TNF)‐alpha were measured using enzyme‐linked immunosorbent assay.
Results: Serum levels of IL‐6 and TNF‐alpha at the acute phase were significantly higher in patients with MI than in control subjects (both p < 0.05). The IL‐6 levels correlated well negatively with ΔEDVI (r = 0.779, p = 0.039), whereas no correlation was found for TNF‐alpha. According to multivariate analysis, IL‐6 at the acute phase was a significant independent predictor for LV remodeling after reperfused MI (p = 0.007).
Conclusions: Circulating IL‐6 levels correlated closely with LV geometric changes during the remodeling process in patients with reperfused MI. Our study addresses the usefulness of another marker for LV remodeling after MI.
Keywords: cytokines, left ventricular remodeling, myocardial infarction
Full Text
The Full Text of this article is available as a PDF (162.4 KB).
References
- 1. Erlebacher JA, Weisse JL, Weisfeldt ML, Bulkley BH: Early dilatation of the infarcted segment in acute transmural myocardial infarction: Role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol 1984; 4: 201–208 [DOI] [PubMed] [Google Scholar]
- 2. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990; 81: 1161–1172 [DOI] [PubMed] [Google Scholar]
- 3. Schuster EH, Bulkley BH: Expansion of transmural myocardial infarction: A pathophysiologic factor in cardiac rupture. Circulation 1979; 60: 1532–1538 [DOI] [PubMed] [Google Scholar]
- 4. Jugdutt BI, Michorowski BL: Role of infarct expansion in rupture of the ventricular septum after acute myocardial infarction: A two dimensional echocardiographic study. Clin Cardiol 1987; 10: 641–652 [DOI] [PubMed] [Google Scholar]
- 5. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT: Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post‐ischemic myocardial inflammation and necrosis. Science 1990; 249: 146–151 [DOI] [PubMed] [Google Scholar]
- 6. Herskowitz A, Choi S, Ansari AA, Wesselingh S: Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995; 146: 419–428 [PMC free article] [PubMed] [Google Scholar]
- 7. Hiasa G, Hamada M, Ikeda S, Hiwada K: Ischemic preconditioning and lipopolysaccharide attenuate nuclear factor–κB activation and gene expression of inflammatory cytokines in the ischemia‐reperfused heart. Jpn Circ J 2001; 65: 984–990 [DOI] [PubMed] [Google Scholar]
- 8. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akashi M, Mitamura H, Ogawa S: C‐reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q‐wave acute myocardial infarction. Circulation 1997; 96: 778–784 [DOI] [PubMed] [Google Scholar]
- 9. Morishima I, Sone T, Tsuboi H, Kondo J, Mukawa H, Kamiya H, Hieda N, Okumura K: Plasma C‐reactive protein predicts left ventricular remodeling and function after a first acute anterior wall myocardial infarction treated with coronary angioplasty: Comparison with brain natriuretic peptide. Clin Cardiol 2002; 25: 112–116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, Mitamura H, Ogawa S: Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: A possible role for left ventricular remodeling. J Am Coll Cardiol 2002; 39: 241–246 [DOI] [PubMed] [Google Scholar]
- 11. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S: Cytokine gene expression after myocardial infarction in rat hearts. Possible implication in left ventricular remodeling. Circulation 1998; 98: 149–156 [DOI] [PubMed] [Google Scholar]
- 12. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL: β‐Adrenergic blockade in developing heart failure. Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000; 101: 2103–2109 [DOI] [PubMed] [Google Scholar]
- 13. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E: Elevation of tumor necrosis factor‐alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149–2153 [DOI] [PubMed] [Google Scholar]
- 14. Kotajima N, Kimura T, Kanda T, Kuwabara A, Fukumura Y, Murakami M, Kobayashi I: Reciprocal increase of circulating interleukin‐10 and interleukin‐6 in patients with acute myocardial infarction. Heart 2001; 86: 704–705 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Jacobs M, Staufenberger S, Gergs U, Meuter K, Brandstatter K, Hafner M, Ertl G, Schorb W: Tumor necrosis factor‐alpha at acute myocardial infarction in rats and effects on cardiac fibroblasts. J Mol Cell Cardiol 1999; 31: 1949–1959 [DOI] [PubMed] [Google Scholar]
- 16. Jeremias I, Kupatt C, Martin‐Villalba A, Habazettl H, Schenkel J, Boekstegers P, Debatin KM: Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 2000; 102: 915–920 [DOI] [PubMed] [Google Scholar]
- 17. Ohtsuka T, Hamada M, Hiasa G, Sasaki O, Suzuki M, Hara Y, Shigematsu Y, Hiwada K: Effect of beta‐blockers on circulating levels of inflammatory and anti‐inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 2001; 37: 412–417 [DOI] [PubMed] [Google Scholar]
- 18. Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, Daikoku S, Matsumoto T, Miyazaki S, Matsuoka H, Takishita S, Kangawa K, Matsuo H, Nonogi H: Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after myocardial infarction. Am Heart J 1998; 135: 21–28 [DOI] [PubMed] [Google Scholar]
- 19. Furman MI, Becker RC, Yarzebski J, Savegeau J, Gore JM, Goldberg RJ: Effect of elevated leukocyte count on in‐hospital mortality following acute myocardial infarction. Am J Cardiol 1996; 78: 945–948 [DOI] [PubMed] [Google Scholar]
- 20. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T, Shimada K: Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992; 24: 579–584 [DOI] [PubMed] [Google Scholar]
- 21. Chandrasekar B, Mitchell DA, Colston JT, Freeman GL: Regulation of CCAAT/enhancer binding protein, interleukin‐6, interleukin‐6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation 1999; 99: 427–433 [DOI] [PubMed] [Google Scholar]